Furthermore, Takano and colleagues found that the PPARγ agonist pioglitazone down-regulated COX-2 and cyclin D1 and inhibited colon cancer proliferation and liver metastasis [118]. This evidence concerns the gene PPARG and malignant colon neoplasm.